CERVIDIL

This brand name is authorized in United States. It is also authorized in Canada, New Zealand, Poland, Singapore.

Active ingredients

The drug CERVIDIL contains one active pharmaceutical ingredient (API):

1	Dinoprostone UNII K7Q1JQR04M - DINOPROSTONE
	Read more about Dinoprostone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CERVIDIL Vaginal insert	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G02AD02	Dinoprostone	G Genito urinary system and sex hormones → G02 Other gynecologicals → G02A Oxytocics → G02AD Prostaglandins
Discover more medicines within G02AD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02231047
NZ	Medicines and Medical Devices Safety Authority	9951
PL	Rejestru Produktów Leczniczych	100404540
SG	Health Sciences Authority	13982P
US	FDA, National Drug Code	55566-2800